Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Seeking Alpha Publishes Article Featuring International Stem Cell Corp. (ISCO) 0 comments
    Apr 5, 2013 1:38 PM | about stocks: ISCO

    International Stem Cell Corp. specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

    Seeking Alpha yesterday published the following article featuring ISCO: seekingalpha.com/article/1320381

    The article titled "Curing Parkinson's: The Alternative Approach - Is There Money To Be Made?" provides an overview of the current treatments available, a few new options under development, and the overall cost of Parkinson's disease on our economy. ISCO took the spotlight with its parthenogenetic stem cell-based approach, which recently generated positive safety and efficacy data during placebo-controlled studies. For more information on these studies, visit dtg.fm/a5Xh.

    Ed Liston, author of the article, wrote, "Let me quickly put a few positives for the ISCO treatment… It is a cure of the underlying disease and not mere mitigation of superficially observable symptoms… It uses cells from unfertilized eggs, therefore, there are no ethical issues associated with the cell source… The cells created using the company's proprietary technique are designed to be compatible with the immune system of the patient and hence, are not likely to be rejected by the patient's body upon introduction."

    Nearly 1 million Americans are currently affected by Parkinson's disease, which is caused by the death of dopamine-generating cells in the brain. The total number of new cases of Parkinson's detected each year in the US is approximately 60,000. According to the Parkinson's Disease Foundation, the cost of the disease to the US economy is approximately $25 billion a year.

    For more information on International Stem Cell Corp. and its hpSC technology, visit InternationalStemCell.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: ISCO
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.